Evidence map›Paper›PMID 41942435›Full record

ArticleNature communications2026

Comprehensive CRISPR/Cas9-based mutagenesis identifies single-amino acid substitutions that abrogate SPEN function in X inactivation.

Corinne Kaufmann, Sarah Sting, Chao Dai, Anton Wutz

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Corinne KaufmannInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0006-5481-428X
Sarah StingInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.
Chao DaiInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.
Anton WutzInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland. awutz@ethz.ch.ORCID http://orcid.org/0000-0002-4377-6330

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 31003A_152814/1
6 · The paper itself

Abstract

While genetic screens have facilitated the dissection of protein function in animal development, advances in systematic point mutagenesis open new opportunities for forward genetics in mammalian cells. Here, we develop a CRISPR/Cas9-mediated base editing screen that allows functional screening of extensive collections of single amino acid substitutions of endogenous proteins. We demonstrate the application on the X-chromosomal Hprt and the autosomal Msh2 gene in diploid male and haploid mouse embryonic stem cells, respectively. Finally, we use this methodology to generate a sequence-function map of the transcriptional co-repressor SPEN in X chromosome inactivation. We demonstrate that the substitution of the SPEN RRM4-residue W522 abrogates X-linked gene repression by Xist RNA and impairs the establishment of H3K27me3 deposition. Our results demonstrate that screening in haploid cells allows efficient identification of mutations that would be recessive in diploid cells, suggesting applications across a wide range of areas.

Indexed as

Amino Acid SubstitutionCRISPR-Cas SystemsX Chromosome InactivationAnimalsDNA-Binding ProteinsHaploidyHistonesHypoxanthine PhosphoribosyltransferaseMiceMouse Embryonic Stem CellsMutagenesisMutS Homolog 2 ProteinRNA, Long NoncodingDNA-Binding ProteinsHistonesHypoxanthine PhosphoribosyltransferaseMutS Homolog 2 ProteinRNA, Long NoncodingXIST non-coding RNA

Identifiers

PMID41942435
PMCPMC13230580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.